All posts in Research

  • Even smokers may benefit from targeted lung cancer treatments

    No matter a patient’s smoking history, when a targetable genetic alteration is present, matching the alteration with the appropriate targeted therapy is associated with a survival benefit of 1.5 years.

Smoking Cessation at University of Colorado Hospital